| Wall Street Journal. Europe 2003 Gautam Naik |
| Title | Subject | Authors |
|---|
| Alnylam, Ribopharma to merge.(Alnylam Pharmaceuticals Inc.) | Business, international | Gautam Naik |
| Aventis says drug for skin cancer did well in trial.(partnership with Genta Inc.) | Business, international | Gautam Naik |
| Chiron said to be near acquiring PowderJect.(Chiron Corp., PowderJect Pharmaceuticals PLC) | Business, international | Gautam Naik, Anita Raghavan |
| Elan may face hurdle selling U.S. drug rights amid probe.(Elan Corp., investigation into marketing practices) | Business, international | Gautam Naik |
| Glaxo loses Paxil court case in U.S.(GlaxoSmithKline, antidepressant drug patent case) | Business, international | Gautam Naik, Susannah Rodgers |
| Glaxo says drug may help fight prostate cancer.(GlaxoSmithKline PLC, Avodart drug) | Business, international | Gautam Naik |
| Glaxo to cut price of AIDS drug used in Africa.(GlaxoSmithKline PLC) | Business, international | Gautam Naik |
| SARS research spurs patent race.(severe acute respiratory syndrome, scientific and corporate patents) | Business, international | Gautam Naik, Michael Waldholz, Antonio Regalado |
| Zimmer pursues a hostile bid for Centerpulse.(Zimmer Holdings Inc., acquisition bid ) | Business, international | Gautam Naik, Robin Sidel |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
